salicylaldehyde isonicotinoyl hydrazone has been researched along with ascorbic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hašková, P; Koubková, L; Kovaříková, P; Macková, E; Simůnek, T; Vávrová, A | 1 |
| Bendová, P; Hašková, P; Hrušková, K; Jansová, H; Kovaříková, P; Macková, E; Simůnek, T; Vávrová, A; Vávrová, K | 1 |
| Chen, YL; Hider, RC; Kong, X; Xie, Y | 1 |
3 other study(ies) available for salicylaldehyde isonicotinoyl hydrazone and ascorbic acid
| Article | Year |
|---|---|
Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity.
Topics: Aldehydes; Animals; Ascorbic Acid; Binding, Competitive; Caspases; Catecholamines; Cell Line; Cell Survival; Coordination Complexes; Cytoprotection; Enzyme Assays; Hydrazones; Iron; Iron Chelating Agents; Myoblasts, Cardiac; Oxidation-Reduction; Oxidative Stress; Rats; Reactive Oxygen Species | 2011 |
Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: novel iron chelators with selective antiproliferative action.
Topics: Aldehydes; Antineoplastic Agents; Apoptosis; Ascorbic Acid; Caspases; Cell Cycle; Cell Line, Tumor; Deferoxamine; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Hydrazones; Iron Chelating Agents; Ketones; Membrane Potential, Mitochondrial; Oxidation-Reduction | 2012 |
The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron.
Topics: Aldehydes; Ascorbic Acid; Edetic Acid; Electrochemical Techniques; Electrodes; Ferric Compounds; Ferrous Compounds; Hydrazones; Hydrogen-Ion Concentration; Iron Chelating Agents; Isoniazid; Kinetics; Oxidation-Reduction; Pyridoxal | 2018 |